Growth Metrics

Merck (MRK) Other Accumulated Expenses (2016 - 2025)

Merck (MRK) has disclosed Other Accumulated Expenses for 17 consecutive years, with $14.5 billion as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 7.81% to $14.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.5 billion through Dec 2025, down 7.81% year-over-year, with the annual reading at $14.5 billion for FY2025, 7.81% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $14.5 billion at Merck, down from $16.2 billion in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $16.5 billion in Q3 2024, with the low at $11.9 billion in Q1 2021.
  • Average Other Accumulated Expenses over 5 years is $14.3 billion, with a median of $14.2 billion recorded in 2021.
  • The sharpest move saw Other Accumulated Expenses grew 21.59% in 2021, then dropped 9.43% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $13.9 billion in 2021, then increased by 2.16% to $14.2 billion in 2022, then increased by 11.35% to $15.8 billion in 2023, then fell by 0.46% to $15.7 billion in 2024, then dropped by 7.81% to $14.5 billion in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $14.5 billion, $16.2 billion, and $14.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.